Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

1.50
+0.8041115.55%
Post-market: 1.41-0.0899-5.99%19:59 EDT
Volume:90.30M
Turnover:119.19M
Market Cap:36.30M
PE:-0.93
High:1.73
Open:0.6870
Low:0.6818
Close:0.6959
52wk High:3.82
52wk Low:0.5555
Shares:24.20M
Float Shares:9.22M
Volume Ratio:2,212.66
T/O Rate:979.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6069
EPS(LYR):-3.5570
ROE:-129.46%
ROA:-53.04%
PB:3.77
PE(LYR):-0.42

Loading ...

Company Profile

Company Name:
MetaVia Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
9
Office Location:
545 Concord Avenue,Suite 210,Cambridge,Massachusetts,United States
Zip Code:
02138
Fax:
- -
Introduction:
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Andrew Koven
Chairman of the Board
Hyung Heon Kim
Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer
D. Gordon Strickland
Director
Jason L. Groves
Director
Mark A. Glickman
Director
Michael Salsbury
Director
Na Yeon Kim
Director

Shareholders

Name
Position
Hyung Heon Kim
Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer